CLINICAL RESEARCH: CONGENITAL HEART DISEASE
Reversible atrioventricular block associated with closure of atrial septal defects using the amplatzer device
Kenji Suda, MD*,
Marie-Josée Raboisson, MD ,
Eric Piette* ,
Nagib S. Dahdah, MD, FACC,* and
Joaquim Miró, MD, FRCP
* Division of Pediatric Cardiology, Department of Pediatrics, Tenri Hospital, Tenri, Japan
Department of Cardiology, Hôpital Louis Pradel, Lyon, France
Division of Cardiology, Hôpital Sainte-Justine, University of Montreal, Montreal, Canada
Manuscript received July 30, 2003;
revised manuscript received October 1, 2003,
accepted December 9, 2003.
* Reprint requests and correspondence: Dr. Nagib S. Dahdah, Hôpital Sainte-Justine, Department of Cardiology, 3175 Cote St. Catherine, Montreal QC H3T1C-5, Canada.
ndahdah{at}pol.net
OBJECTIVES: We sought to determine the incidence, nature, and predisposing factors of atrioventricular block (AVB) associated with closure of atrial septal defects (ASDs) using the Amplatzer septal occluder (ASO).
BACKGROUND: In our institution, 162 patients underwent ASD closure using ASO between December 1997 and December 2001. This includes small children with large defects.
METHODS: Electrocardiographic tracings during ASO implantation and at follow-up visits were reviewed. Anatomic characteristics and device size were assessed as potential risk factors for AVB.
RESULTS: Ten patients (6.2%) presented with new-onset (n = 9) or aggravation of preexisting (n = 1) AVB. Atrioventricular block occurred during the procedure (n = 3) or was first noted one day to one week later (n = 7). Patients had first-degree (n = 4), second-degree Wenckebach (n = 4), or third-degree (n = 2) AVB, with no symptoms or hemodynamic compromise. First-degree AVB persisted in two patients at 12 and 33 months of follow-up, whereas most recovered normal AV conduction within one (n = 7) or six months (n = 1). A larger shunt (Qp/Qs ratio 2.8 ± 0.9 vs. 2.1 ± 0.8, p < 0.01) and device size (24 ± 5 vs. 19 ± 6 mm, p < 0.01) were the only determinant factors for AVB. A device size  19 mm was used in 90% (9 of 10) of patients who developed AVB, as compared with 49% of those without AVB (p < 0.02).
CONCLUSIONS: Closure of ASDs using the large ASO can be associated with the development of AV block and mandate a closer follow-up. In our series, however, all AVBs resolved or improved spontaneously, with no recurrence at mid-term follow-up.
|
Abbreviations and Acronyms
| | ASD | = atrial septal defect | | ASO | = Amplatzer septal occluder | | AV | = atrioventricular | | AVB | = atrioventricular block | | ECG | = electrocardiogram or electrocardiographic | | Qp/Qs | = pulmonary to systemic flow ratio |
|
This article has been cited by other articles:
|
|
|
|
 
S. M. Singh and S. Das
Delayed Heart Block After Temporary Balloon Occlusion of a Secundum Atrial Septal Defect.
Circ Arrhythm Electrophysiol,
January 1, 2008;
1(5):
405 - 406.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Jux, H. Bertram, P. Wohlsein, M. Bruegmann, and T. Paul
Interventional Atrial Septal Defect Closure Using a Totally Bioresorbable Occluder Matrix: Development and Preclinical Evaluation of the BioSTAR Device
J. Am. Coll. Cardiol.,
July 4, 2006;
48(1):
161 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Santoro, M Pascotto, S Caputo, F Cerrato, M Cappelli Bigazzi, M T Palladino, C Iacono, M Carrozza, M G Russo, and R Calabro
Similar cardiac remodelling after transcatheter atrial septal defect closure in children and young adults
Heart,
July 1, 2006;
92(7):
958 - 962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Kaplan and P. Denes
Reversible atrioventricular block and the Amplatzer device
J. Am. Coll. Cardiol.,
April 19, 2005;
45(8):
1306 - 1306.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Dahdah and J. Miro
Reply
J. Am. Coll. Cardiol.,
April 19, 2005;
45(8):
1306 - 1306.
[Full Text]
[PDF]
|
|
|
|
